A Beaverton family is gaining momentum in their quest for treatment for their son’s rare genetic disorder, thanks to new feedback from the U.S. Food and Drug Administration (FDA). Six-year-old Raiden Pham has been diagnosed with a condition that affects his muscle and nerve development. His parents, determined to find a gene therapy solution, are now working to raise $2 million to fund future treatment options.
The FDA’s recent communication has provided the Pham family with a renewed sense of hope. They believe this guidance may pave the way for potential therapies that could significantly improve Raiden’s quality of life. “We are encouraged by the progress and are optimistic that we can make a difference,” said Raiden’s mother, who has been actively involved in advocacy and fundraising efforts.
To support their cause, the family is participating in the upcoming Shamrock Run, a popular community event that promotes health and wellness while also raising funds for various charities. The Phams are aiming to rally the community around their mission, encouraging others to join their fundraising efforts. “Every dollar counts in helping us move closer to a treatment,” Raiden’s father emphasized.
The Pham family has been deeply affected by Raiden’s condition, which has required numerous medical appointments, therapies, and ongoing care. They have connected with other families facing similar challenges and have found strength in their shared experiences. This network has empowered them to take proactive steps in fundraising and awareness campaigns.
The fundraising goal of $2 million is ambitious but necessary to cover research, clinical trials, and potential gene therapy treatments. The family is leveraging social media platforms to share Raiden’s story, aiming to reach a wider audience and encourage contributions from those who may want to help. “We believe that together, we can create a brighter future for Raiden and others like him,” they stated.
As the Shamrock Run approaches, the Phams are also exploring partnerships with local businesses and organizations that may be willing to support their initiative. The community’s response so far has been encouraging, with many local residents expressing their willingness to participate in the run and support the cause.
Every step taken in this journey brings the family closer to their ultimate goal: securing a viable treatment for Raiden. The support from the FDA, combined with community engagement, gives them hope that their efforts will lead to significant advancements in medical treatment for rare genetic disorders.
In a world where such conditions often go unnoticed, the Pham family’s dedication serves as a reminder of the importance of community support and advocacy. They hope that their story will inspire others to join in the fight against rare diseases, highlighting the critical need for funding and research in this area.
